Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
Authors
Keywords
COVID-19, Meta-analysis, Mortality, Tocilizumab, Toxicity
Journal
CLINICAL MICROBIOLOGY AND INFECTION
Volume 27, Issue 2, Pages 215-227
Publisher
Elsevier BV
Online
2020-11-06
DOI
10.1016/j.cmi.2020.10.036
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tocilizumab not associated with increased infection risk after CAR T - Implications for COVID-19?
- (2020) Matthew J Frigault et al. BLOOD
- Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients
- (2020) Xiaohua Chen et al. CLINICAL INFECTIOUS DISEASES
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- The many faces of the anti-COVID immune response
- (2020) Santosha A. Vardhana et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE)
- (2020) Marta Colaneri et al. Microorganisms
- Tocilizumab for treatment of mechanically ventilated patients with COVID-19
- (2020) Emily C Somers et al. CLINICAL INFECTIOUS DISEASES
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID‐19: a retrospective cohort study.
- (2020) Johannes Eimer et al. JOURNAL OF INTERNAL MEDICINE
- Efficacy of hydroxychloroquine and tocilizumab in patients with COVID-19: A single-center retrospective chart review (Preprint)
- (2020) Sohaib Roomi et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
- (2020) Luca Carsana et al. LANCET INFECTIOUS DISEASES
- Decreased Mortality in Coronavirus Disease 2019 Patients Treated With Tocilizumab: A Rapid Systematic Review and Meta-analysis of Observational Studies
- (2020) Jishnu Malgie et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
- (2018) Yaseen M. Arabi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality
- (2018) M.C. Beumer et al. JOURNAL OF CRITICAL CARE
- Survival biases lead to flawed conclusions in observational treatment studies of influenza patients
- (2017) Martin Wolkewitz et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Methods for time-varying exposure related problems in pharmacoepidemiology: An overview
- (2017) Laura Pazzagli et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
- (2016) Bita Shakoory et al. CRITICAL CARE MEDICINE
- Immunotherapeutic implications of IL-6 blockade for cytokine storm
- (2016) Toshio Tanaka et al. Immunotherapy
- Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis
- (2016) Lonneke A. van Vught et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Intensive care unit-acquired blood stream infections: a 5-year retrospective analysis of a single tertiary care hospital in Korea
- (2014) S. J. Lim et al. INFECTION
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Living Systematic Reviews: An Emerging Opportunity to Narrow the Evidence-Practice Gap
- (2014) Julian H. Elliott et al. PLOS MEDICINE
- IL-6/IL-6 receptor system and its role in physiological and pathological conditions
- (2011) Masahiko Mihara et al. CLINICAL SCIENCE
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
- (2011) Gordon Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The acute phase protein response in patients receiving subcutaneous IL-6
- (2010) R. E. BANKS et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias
- (2010) Imad M. Tleyjeh et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry
- (2008) Jaime L. Peters et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now